RUBICON
NSE#505 by turnoverRubicon Research Limited
Key statistics
- Open
- ₹1,679.30
- Day range
- 1,661.10 – 1,695.90
- 52-week range
- —
- From 52w high
- —
- Volume
- 1.29L
- Turnover
- ₹21.5Cr
- Delivery
- 49.9%
- Rel volume
- 0.50×
- RSI (14)
- 43.3
- ATR (14)
- 68.99
- SMA 50
- 1,677.04
- SMA 200
- 1,100.28
20-day avg 51.0%
Performance
- 1 day
- +0.01%
- 1 week
- -4.27%
- 1 month
- -7.83%
- 3 months
- +18.08%
- 6 months
- +118.44%
- 1 year
- —
Delivery percentage
- Latest
- 49.9%
- 20-day avg
- 51.0%
- 1-year avg
- 44.8%
- Percentile
- 68th
- Range
- 10.1–81.7%
25 Sept 2026
Against its own sessions
234 sessions
Over the last 20 sessions RUBICON settled 51.0% of its traded quantity, which is above average for an NSE equity. Its one-year average is 44.8%, so recent sessions are running 6.2 points higher than usual.
What delivery percentage measuresScan the whole market on delivery
Fundamentals
- Market cap
- ₹27,748 Cr
- P/E (TTM)
- 96.28
- EPS (TTM)
- ₹17.41
- Shares outstanding
- 16.54Cr
- Listed
- 16 Oct 2025
Q1 FY27
Classification
- Macro sector
- Healthcare
- Sector
- Healthcare
- Industry
- Pharmaceuticals & Biotechnology
- Basic industry
- Pharmaceuticals
NSE publishes no history for this taxonomy, so it is today’s classification rather than the one that held in the past.
Growthlatest filed quarter Q1 FY27
- Revenue YoY
- —
- Profit YoY
- —
- Revenue QoQ
- +3.97%
- Profit QoQ
- +10.41%
- Interest cost YoY
- —
Compound growth
Not enough filed history for a compound growth rate yet.
Trailing-twelve-month figures against the same measure that many years earlier, on one reporting basis throughout. Blank where the filed history is too short or either end of the window was a loss — never a number built from less.
About
- ISIN
- INE506V01022
- Series
- EQ
- History from
- 16 Oct 2025
- Sessions
- 234
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 25 Sept 2026.